Index by author

01 August 2000; volume 16, issue 2

A

  1. Al-Kattan, K

    1. Al-Mobeireek, AF, and K Al-Kattan. ""Coffee grounds" through the chest tube." European Respiratory Journal 16.2 (2000): 361-363. Web. 24 June. 2021.

  2. Al-Mobeireek, AF

    1. Al-Mobeireek, AF, and K Al-Kattan. ""Coffee grounds" through the chest tube." European Respiratory Journal 16.2 (2000): 361-363. Web. 24 June. 2021.

  3. Altpeter, E

    1. Helbling, P et al "Surveillance of antituberculosis drug resistance in Switzerland 1995-1997: the central link." European Respiratory Journal 16.2 (2000): 200-202. Web. 24 June. 2021.

  4. Alving, K

    1. Palm, JP et al "Characterization of exhaled nitric oxide: introducing a new reproducible method for nasal nitric oxide measurements." European Respiratory Journal 16.2 (2000): 236-241. Web. 24 June. 2021.

  5. Antonaglia, V

    1. Antonaglia, V et al "Bedside assessment of respiratory viscoelastic properties in ventilated patients." European Respiratory Journal 16.2 (2000): 302-308. Web. 24 June. 2021.

B

  1. Bachmann, S

    1. Stey, C et al "The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review." European Respiratory Journal 16.2 (2000): 253-262. Web. 24 June. 2021.

  2. Badcock, CA

    1. Reddel, HK et al "Optimal asthma control, starting with high doses of inhaled budesonide." European Respiratory Journal 16.2 (2000): 226-235. Web. 24 June. 2021.

  3. Barsky, SH

    1. De las Heras, M et al "Evidence for a protein related immunologically to the jaagsiekte sheep retrovirus in some human lung tumours." European Respiratory Journal 16.2 (2000): 330-332. Web. 24 June. 2021.

  4. Bauer, J

    1. Thomsen, VO et al "Results from 8 yrs of susceptibility testing of clinical Mycobacterium tuberculosis isolates in Denmark." European Respiratory Journal 16.2 (2000): 203-208. Web. 24 June. 2021.

  5. Belouchi, NE

    1. Roche, N et al "Dermatophagoides pteronyssinus and bioelectric properties of airway epithelium: role of cysteine proteases." European Respiratory Journal 16.2 (2000): 309-315. Web. 24 June. 2021.

  6. Borgdorff, MW

    1. Borgdorff, MW et al "Defaulting from tuberculosis treatment in The Netherlands: rates, risk factors and trend in the period 1993-1997." European Respiratory Journal 16.2 (2000): 209-213. Web. 24 June. 2021.

  7. Borzone, G

    1. Diaz, O et al "Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest." European Respiratory Journal 16.2 (2000): 269-275. Web. 24 June. 2021.

  8. Bottcher, M

    1. Loppow, D et al "Flow cytometric analysis of the effect of dithiothreitol on leukocyte surface markers." European Respiratory Journal 16.2 (2000): 324-329. Web. 24 June. 2021.

  9. Broekmans, JF

    1. Borgdorff, MW et al "Defaulting from tuberculosis treatment in The Netherlands: rates, risk factors and trend in the period 1993-1997." European Respiratory Journal 16.2 (2000): 209-213. Web. 24 June. 2021.

  10. Brogan, TV

    1. Brogan, TV et al "Pulmonary NO synthase inhibition and inspired CO2: effects on V'/Q' and pulmonary blood flow distribution." European Respiratory Journal 16.2 (2000): 288-295. Web. 24 June. 2021.

  11. Brown, A

    1. Raeside, DA et al "Pulmonary artery pressure measurement during exercise testing in patients with suspected pulmonary hypertension." European Respiratory Journal 16.2 (2000): 282-287. Web. 24 June. 2021.

C

  1. Canivet, JL

    1. Mathy-Hartert, M et al "Nitrated proteins in bronchoalveolar lavage fluid of patients at risk of ventilator-associated bronchopneumonia." European Respiratory Journal 16.2 (2000): 296-301. Web. 24 June. 2021.

  2. Castro, DJ

    1. Castro, DJ, GD Nuevo, and E Perez-Rodriguez. "Diagnostic utility of eosinophils in pleural fluid." European Respiratory Journal 16.2 (2000): 374. Web. 24 June. 2021.

  3. Chinet, TC

    1. Roche, N et al "Dermatophagoides pteronyssinus and bioelectric properties of airway epithelium: role of cysteine proteases." European Respiratory Journal 16.2 (2000): 309-315. Web. 24 June. 2021.

  4. Cleland, J

    1. Raeside, DA et al "Pulmonary artery pressure measurement during exercise testing in patients with suspected pulmonary hypertension." European Respiratory Journal 16.2 (2000): 282-287. Web. 24 June. 2021.

D

  1. Damas, P

    1. Mathy-Hartert, M et al "Nitrated proteins in bronchoalveolar lavage fluid of patients at risk of ventilator-associated bronchopneumonia." European Respiratory Journal 16.2 (2000): 296-301. Web. 24 June. 2021.

  2. Deby-Dupont, G

    1. Mathy-Hartert, M et al "Nitrated proteins in bronchoalveolar lavage fluid of patients at risk of ventilator-associated bronchopneumonia." European Respiratory Journal 16.2 (2000): 296-301. Web. 24 June. 2021.

  3. De las Heras, M

    1. De las Heras, M et al "Evidence for a protein related immunologically to the jaagsiekte sheep retrovirus in some human lung tumours." European Respiratory Journal 16.2 (2000): 330-332. Web. 24 June. 2021.

  4. De Simoni, L

    1. Antonaglia, V et al "Bedside assessment of respiratory viscoelastic properties in ventilated patients." European Respiratory Journal 16.2 (2000): 302-308. Web. 24 June. 2021.

  5. Diaz, O

    1. Diaz, O et al "Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest." European Respiratory Journal 16.2 (2000): 269-275. Web. 24 June. 2021.

  6. Douma, WR

    1. Douma, WR et al "Changes in peak expiratory flow indices as a proxy for changes in bronchial hyperresponsiveness. Dutch Chronic Non-Specific Lung Disease study group." European Respiratory Journal 16.2 (2000): 220-225. Web. 24 June. 2021.

  7. Drobniewski, F

    1. Schwoebel, V et al "Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group." European Respiratory Journal 16.2 (2000): 364-371. Web. 24 June. 2021.

  8. Duguet, A

    1. Martin, JG, A Duguet, and DH Eidelman. "The contribution of airway smooth muscle to airway narrowing and airway hyperresponsiveness in disease." European Respiratory Journal 16.2 (2000): 349-354. Web. 24 June. 2021.

E

  1. Egan, J

    1. De las Heras, M et al "Evidence for a protein related immunologically to the jaagsiekte sheep retrovirus in some human lung tumours." European Respiratory Journal 16.2 (2000): 330-332. Web. 24 June. 2021.

  2. Eidelman, DH

    1. Martin, JG, A Duguet, and DH Eidelman. "The contribution of airway smooth muscle to airway narrowing and airway hyperresponsiveness in disease." European Respiratory Journal 16.2 (2000): 349-354. Web. 24 June. 2021.

F

  1. Freling, G

    1. Pouw, EM et al "Muscle metabolic status in patients with severe COPD with and without long-term prednisolone." European Respiratory Journal 16.2 (2000): 247-252. Web. 24 June. 2021.

G

  1. Georgopoulos, D

    1. Mouloudi, E et al "Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of flow pattern." European Respiratory Journal 16.2 (2000): 263-268. Web. 24 June. 2021.

  2. Gercken, G

    1. Loppow, D et al "Flow cytometric analysis of the effect of dithiothreitol on leukocyte surface markers." European Respiratory Journal 16.2 (2000): 324-329. Web. 24 June. 2021.

  3. Ghezzo, H

    1. Diaz, O et al "Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest." European Respiratory Journal 16.2 (2000): 269-275. Web. 24 June. 2021.

  4. Gimenez-Mas, JA

    1. De las Heras, M et al "Evidence for a protein related immunologically to the jaagsiekte sheep retrovirus in some human lung tumours." European Respiratory Journal 16.2 (2000): 330-332. Web. 24 June. 2021.

  5. Glismann, S

    1. Thomsen, VO et al "Results from 8 yrs of susceptibility testing of clinical Mycobacterium tuberculosis isolates in Denmark." European Respiratory Journal 16.2 (2000): 203-208. Web. 24 June. 2021.

  6. Gosker, HR

    1. Pouw, EM et al "Muscle metabolic status in patients with severe COPD with and without long-term prednisolone." European Respiratory Journal 16.2 (2000): 247-252. Web. 24 June. 2021.

  7. Graf, P

    1. Palm, JP et al "Characterization of exhaled nitric oxide: introducing a new reproducible method for nasal nitric oxide measurements." European Respiratory Journal 16.2 (2000): 236-241. Web. 24 June. 2021.

  8. Groen, HJ

    1. Steenhuis, LH et al "Diffusion capacity and haemodynamics in primary and chronic thromboembolic pulmonary hypertension." European Respiratory Journal 16.2 (2000): 276-281. Web. 24 June. 2021.

  9. Gullo, A

    1. Antonaglia, V et al "Bedside assessment of respiratory viscoelastic properties in ventilated patients." European Respiratory Journal 16.2 (2000): 302-308. Web. 24 June. 2021.

H

  1. Hargreave, FE

    1. Leigh, R, M Kelly, and FE Hargreave. "Bronchial hyperresponsiveness and airway inflammation markers in nonasthmatics with allergic rhinitis." European Respiratory Journal 16.2 (2000): 374. Web. 24 June. 2021.

  2. Hartung, TK

    1. Robson, AG, TK Hartung, and JA Innes. "Laboratory assessment of fitness to fly in patients with lung disease: a practical approach." European Respiratory Journal 16.2 (2000): 214-219. Web. 24 June. 2021.

  3. Hasleton, P

    1. De las Heras, M et al "Evidence for a protein related immunologically to the jaagsiekte sheep retrovirus in some human lung tumours." European Respiratory Journal 16.2 (2000): 330-332. Web. 24 June. 2021.

  4. Hedges, RG

    1. Brogan, TV et al "Pulmonary NO synthase inhibition and inspired CO2: effects on V'/Q' and pulmonary blood flow distribution." European Respiratory Journal 16.2 (2000): 288-295. Web. 24 June. 2021.

  5. Helbling, P

    1. Helbling, P et al "Surveillance of antituberculosis drug resistance in Switzerland 1995-1997: the central link." European Respiratory Journal 16.2 (2000): 200-202. Web. 24 June. 2021.

  6. Hill, SR

    1. Partridge, MR, and SR Hill. "Enhancing care for people with asthma: the role of communication, education, training and self-management. 1998 World Asthma Meeting Education and Delivery of Care Working Group." European Respiratory Journal 16.2 (2000): 333-348. Web. 24 June. 2021.

  7. Hirvonen, MR

    1. Purokivi, M et al "Reproducibility of measurements of exhaled NO, and cell count and cytokine concentrations in induced sputum." European Respiratory Journal 16.2 (2000): 242-246. Web. 24 June. 2021.

  8. Hlastala, MP

    1. Brogan, TV et al "Pulmonary NO synthase inhibition and inspired CO2: effects on V'/Q' and pulmonary blood flow distribution." European Respiratory Journal 16.2 (2000): 288-295. Web. 24 June. 2021.

  9. Hoffner, SE

    1. Schwoebel, V et al "Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group." European Respiratory Journal 16.2 (2000): 364-371. Web. 24 June. 2021.

  10. Holz, O

    1. Holz, O, J Kips, and H Magnussen. "Update on sputum methodology." European Respiratory Journal 16.2 (2000): 355-359. Web. 24 June. 2021.

  11. Huchon, GJ

    1. Roche, N et al "Dermatophagoides pteronyssinus and bioelectric properties of airway epithelium: role of cysteine proteases." European Respiratory Journal 16.2 (2000): 309-315. Web. 24 June. 2021.

I

  1. Innes, JA

    1. Robson, AG, TK Hartung, and JA Innes. "Laboratory assessment of fitness to fly in patients with lung disease: a practical approach." European Respiratory Journal 16.2 (2000): 214-219. Web. 24 June. 2021.

J

  1. Jenkins, CR

    1. Reddel, HK et al "Optimal asthma control, starting with high doses of inhaled budesonide." European Respiratory Journal 16.2 (2000): 226-235. Web. 24 June. 2021.

  2. Jorres, RA

    1. Loppow, D et al "Flow cytometric analysis of the effect of dithiothreitol on leukocyte surface markers." European Respiratory Journal 16.2 (2000): 324-329. Web. 24 June. 2021.

  3. Julie, C

    1. Roche, N et al "Dermatophagoides pteronyssinus and bioelectric properties of airway epithelium: role of cysteine proteases." European Respiratory Journal 16.2 (2000): 309-315. Web. 24 June. 2021.

K

  1. Kalisvaart, NA

    1. Borgdorff, MW et al "Defaulting from tuberculosis treatment in The Netherlands: rates, risk factors and trend in the period 1993-1997." European Respiratory Journal 16.2 (2000): 209-213. Web. 24 June. 2021.

  2. Kelly, M

    1. Leigh, R, M Kelly, and FE Hargreave. "Bronchial hyperresponsiveness and airway inflammation markers in nonasthmatics with allergic rhinitis." European Respiratory Journal 16.2 (2000): 374. Web. 24 June. 2021.

  3. Kerstjens, HA

    1. Douma, WR et al "Changes in peak expiratory flow indices as a proxy for changes in bronchial hyperresponsiveness. Dutch Chronic Non-Specific Lung Disease study group." European Respiratory Journal 16.2 (2000): 220-225. Web. 24 June. 2021.

  4. Kips, J

    1. Holz, O, J Kips, and H Magnussen. "Update on sputum methodology." European Respiratory Journal 16.2 (2000): 355-359. Web. 24 June. 2021.

  5. Koerts-de Lang, E

    1. Pouw, EM et al "Muscle metabolic status in patients with severe COPD with and without long-term prednisolone." European Respiratory Journal 16.2 (2000): 247-252. Web. 24 June. 2021.

  6. Koeter, GH

    1. Douma, WR et al "Changes in peak expiratory flow indices as a proxy for changes in bronchial hyperresponsiveness. Dutch Chronic Non-Specific Lung Disease study group." European Respiratory Journal 16.2 (2000): 220-225. Web. 24 June. 2021.
    2. Steenhuis, LH et al "Diffusion capacity and haemodynamics in primary and chronic thromboembolic pulmonary hypertension." European Respiratory Journal 16.2 (2000): 276-281. Web. 24 June. 2021.

  7. Kondili, E

    1. Mouloudi, E et al "Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of flow pattern." European Respiratory Journal 16.2 (2000): 263-268. Web. 24 June. 2021.

L

  1. Lambregts-van Weezenbeek, CS

    1. Schwoebel, V et al "Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group." European Respiratory Journal 16.2 (2000): 364-371. Web. 24 June. 2021.

  2. Lamy, M

    1. Mathy-Hartert, M et al "Nitrated proteins in bronchoalveolar lavage fluid of patients at risk of ventilator-associated bronchopneumonia." European Respiratory Journal 16.2 (2000): 296-301. Web. 24 June. 2021.

  3. Lange, P

    1. Vestbo, J, and P Lange. "Is lung function really a good parameter in evaluating the long-term effects of inhaled corticosteroids in COPD?." European Respiratory Journal 16.2 (2000): 372-373. Web. 24 June. 2021.

  4. Larson, E

    1. De las Heras, M et al "Evidence for a protein related immunologically to the jaagsiekte sheep retrovirus in some human lung tumours." European Respiratory Journal 16.2 (2000): 330-332. Web. 24 June. 2021.

  5. Ledoux, D

    1. Mathy-Hartert, M et al "Nitrated proteins in bronchoalveolar lavage fluid of patients at risk of ventilator-associated bronchopneumonia." European Respiratory Journal 16.2 (2000): 296-301. Web. 24 June. 2021.

  6. Leigh, R

    1. Leigh, R, M Kelly, and FE Hargreave. "Bronchial hyperresponsiveness and airway inflammation markers in nonasthmatics with allergic rhinitis." European Respiratory Journal 16.2 (2000): 374. Web. 24 June. 2021.

  7. Leiva, A

    1. Diaz, O et al "Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest." European Respiratory Journal 16.2 (2000): 269-275. Web. 24 June. 2021.

  8. Lillebaek, T

    1. Thomsen, VO et al "Results from 8 yrs of susceptibility testing of clinical Mycobacterium tuberculosis isolates in Denmark." European Respiratory Journal 16.2 (2000): 203-208. Web. 24 June. 2021.

  9. Lisboa, C

    1. Diaz, O et al "Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest." European Respiratory Journal 16.2 (2000): 269-275. Web. 24 June. 2021.

  10. Loddenkemper, R

    1. Loddenkemper, R. "The need for antituberculosis drug resistance surveillance in Europe." European Respiratory Journal 16.2 (2000): 195-196. Web. 24 June. 2021.

  11. Loppow, D

    1. Loppow, D et al "Flow cytometric analysis of the effect of dithiothreitol on leukocyte surface markers." European Respiratory Journal 16.2 (2000): 324-329. Web. 24 June. 2021.

  12. Lundberg, JO

    1. Palm, JP et al "Characterization of exhaled nitric oxide: introducing a new reproducible method for nasal nitric oxide measurements." European Respiratory Journal 16.2 (2000): 236-241. Web. 24 June. 2021.

M

  1. Madhok, R

    1. Raeside, DA et al "Pulmonary artery pressure measurement during exercise testing in patients with suspected pulmonary hypertension." European Respiratory Journal 16.2 (2000): 282-287. Web. 24 June. 2021.

  2. Magnussen, H

    1. Loppow, D et al "Flow cytometric analysis of the effect of dithiothreitol on leukocyte surface markers." European Respiratory Journal 16.2 (2000): 324-329. Web. 24 June. 2021.
    2. Holz, O, J Kips, and H Magnussen. "Update on sputum methodology." European Respiratory Journal 16.2 (2000): 355-359. Web. 24 June. 2021.

  3. Marks, GB

    1. Reddel, HK et al "Optimal asthma control, starting with high doses of inhaled budesonide." European Respiratory Journal 16.2 (2000): 226-235. Web. 24 June. 2021.

  4. Martin, C

    1. Martin, C, V Ullrich, and S Uhlig. "Effects of the thromboxane receptor agonist U46619 and endothelin-1 on large and small airways." European Respiratory Journal 16.2 (2000): 316-323. Web. 24 June. 2021.

  5. Martin, JG

    1. Martin, JG, A Duguet, and DH Eidelman. "The contribution of airway smooth muscle to airway narrowing and airway hyperresponsiveness in disease." European Respiratory Journal 16.2 (2000): 349-354. Web. 24 June. 2021.

  6. Mathy-Hartert, M

    1. Mathy-Hartert, M et al "Nitrated proteins in bronchoalveolar lavage fluid of patients at risk of ventilator-associated bronchopneumonia." European Respiratory Journal 16.2 (2000): 296-301. Web. 24 June. 2021.

  7. McKinney, S

    1. Brogan, TV et al "Pulmonary NO synthase inhibition and inspired CO2: effects on V'/Q' and pulmonary blood flow distribution." European Respiratory Journal 16.2 (2000): 288-295. Web. 24 June. 2021.

  8. Medici, TC

    1. Stey, C et al "The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review." European Respiratory Journal 16.2 (2000): 253-262. Web. 24 June. 2021.

  9. Milic-Emil, J

    1. Diaz, O et al "Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest." European Respiratory Journal 16.2 (2000): 269-275. Web. 24 June. 2021.

  10. Milic-Emili, J

    1. Antonaglia, V et al "Bedside assessment of respiratory viscoelastic properties in ventilated patients." European Respiratory Journal 16.2 (2000): 302-308. Web. 24 June. 2021.

  11. Moro, ML

    1. Schwoebel, V et al "Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group." European Respiratory Journal 16.2 (2000): 364-371. Web. 24 June. 2021.

  12. Mouloudi, E

    1. Mouloudi, E et al "Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of flow pattern." European Respiratory Journal 16.2 (2000): 263-268. Web. 24 June. 2021.

N

  1. Naeije, R

    1. Naeije, R. "Preflight medical screening of patients." European Respiratory Journal 16.2 (2000): 197-199. Web. 24 June. 2021.

  2. Nagelkerke, NJ

    1. Borgdorff, MW et al "Defaulting from tuberculosis treatment in The Netherlands: rates, risk factors and trend in the period 1993-1997." European Respiratory Journal 16.2 (2000): 209-213. Web. 24 June. 2021.

  3. Nuevo, GD

    1. Castro, DJ, GD Nuevo, and E Perez-Rodriguez. "Diagnostic utility of eosinophils in pleural fluid." European Respiratory Journal 16.2 (2000): 374. Web. 24 June. 2021.

  4. Nys, M

    1. Mathy-Hartert, M et al "Nitrated proteins in bronchoalveolar lavage fluid of patients at risk of ventilator-associated bronchopneumonia." European Respiratory Journal 16.2 (2000): 296-301. Web. 24 June. 2021.

O

  1. Ortin, A

    1. De las Heras, M et al "Evidence for a protein related immunologically to the jaagsiekte sheep retrovirus in some human lung tumours." European Respiratory Journal 16.2 (2000): 330-332. Web. 24 June. 2021.

P

  1. Palm, JP

    1. Palm, JP et al "Characterization of exhaled nitric oxide: introducing a new reproducible method for nasal nitric oxide measurements." European Respiratory Journal 16.2 (2000): 236-241. Web. 24 June. 2021.

  2. Palmarini, M

    1. De las Heras, M et al "Evidence for a protein related immunologically to the jaagsiekte sheep retrovirus in some human lung tumours." European Respiratory Journal 16.2 (2000): 330-332. Web. 24 June. 2021.

  3. Partridge, MR

    1. Partridge, MR, and SR Hill. "Enhancing care for people with asthma: the role of communication, education, training and self-management. 1998 World Asthma Meeting Education and Delivery of Care Working Group." European Respiratory Journal 16.2 (2000): 333-348. Web. 24 June. 2021.

  4. Patel, KR

    1. Raeside, DA et al "Pulmonary artery pressure measurement during exercise testing in patients with suspected pulmonary hypertension." European Respiratory Journal 16.2 (2000): 282-287. Web. 24 June. 2021.

  5. Peacock, AJ

    1. Raeside, DA et al "Pulmonary artery pressure measurement during exercise testing in patients with suspected pulmonary hypertension." European Respiratory Journal 16.2 (2000): 282-287. Web. 24 June. 2021.

  6. Peratoner, A

    1. Antonaglia, V et al "Bedside assessment of respiratory viscoelastic properties in ventilated patients." European Respiratory Journal 16.2 (2000): 302-308. Web. 24 June. 2021.

  7. Perez-Rodriguez, E

    1. Castro, DJ, GD Nuevo, and E Perez-Rodriguez. "Diagnostic utility of eosinophils in pleural fluid." European Respiratory Journal 16.2 (2000): 374. Web. 24 June. 2021.

  8. Pfyffer, GE

    1. Helbling, P et al "Surveillance of antituberculosis drug resistance in Switzerland 1995-1997: the central link." European Respiratory Journal 16.2 (2000): 200-202. Web. 24 June. 2021.

  9. Postma, DS

    1. Douma, WR et al "Changes in peak expiratory flow indices as a proxy for changes in bronchial hyperresponsiveness. Dutch Chronic Non-Specific Lung Disease study group." European Respiratory Journal 16.2 (2000): 220-225. Web. 24 June. 2021.

  10. Pouw, EM

    1. Pouw, EM et al "Muscle metabolic status in patients with severe COPD with and without long-term prednisolone." European Respiratory Journal 16.2 (2000): 247-252. Web. 24 June. 2021.

  11. Prinianakis, G

    1. Mouloudi, E et al "Bronchodilator delivery by metered-dose inhaler in mechanically ventilated COPD patients: influence of flow pattern." European Respiratory Journal 16.2 (2000): 263-268. Web. 24 June. 2021.

  12. Purokivi, M

    1. Purokivi, M et al "Reproducibility of measurements of exhaled NO, and cell count and cytokine concentrations in induced sputum." European Respiratory Journal 16.2 (2000): 242-246. Web. 24 June. 2021.

R

  1. Raeber, PA

    1. Helbling, P et al "Surveillance of antituberculosis drug resistance in Switzerland 1995-1997: the central link." European Respiratory Journal 16.2 (2000): 200-202. Web. 24 June. 2021.

  2. Raeside, DA

    1. Raeside, DA et al "Pulmonary artery pressure measurement during exercise testing in patients with suspected pulmonary hypertension." European Respiratory Journal 16.2 (2000): 282-287. Web. 24 June. 2021.

  3. Randell, J

    1. Purokivi, M et al "Reproducibility of measurements of exhaled NO, and cell count and cytokine concentrations in induced sputum." European Respiratory Journal 16.2 (2000): 242-246. Web. 24 June. 2021.

  4. Raviglione, MC

    1. Schwoebel, V et al "Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group." European Respiratory Journal 16.2 (2000): 364-371. Web. 24 June. 2021.

  5. Reddel, HK

    1. Reddel, HK et al "Optimal asthma control, starting with high doses of inhaled budesonide." European Respiratory Journal 16.2 (2000): 226-235. Web. 24 June. 2021.

  6. Rieder, HL

    1. Schwoebel, V et al "Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group." European Respiratory Journal 16.2 (2000): 364-371. Web. 24 June. 2021.

  7. Robertson, HT

    1. Brogan, TV et al "Pulmonary NO synthase inhibition and inspired CO2: effects on V'/Q' and pulmonary blood flow distribution." European Respiratory Journal 16.2 (2000): 288-295. Web. 24 June. 2021.

  8. Robson, AG

    1. Robson, AG, TK Hartung, and JA Innes. "Laboratory assessment of fitness to fly in patients with lung disease: a practical approach." European Respiratory Journal 16.2 (2000): 214-219. Web. 24 June. 2021.

  9. Roche, N

    1. Roche, N et al "Dermatophagoides pteronyssinus and bioelectric properties of airway epithelium: role of cysteine proteases." European Respiratory Journal 16.2 (2000): 309-315. Web. 24 June. 2021.

  10. Roos, CM

    1. Douma, WR et al "Changes in peak expiratory flow indices as a proxy for changes in bronchial hyperresponsiveness. Dutch Chronic Non-Specific Lung Disease study group." European Respiratory Journal 16.2 (2000): 220-225. Web. 24 June. 2021.

S

  1. Salome, CM

    1. Reddel, HK et al "Optimal asthma control, starting with high doses of inhaled budesonide." European Respiratory Journal 16.2 (2000): 226-235. Web. 24 June. 2021.

  2. Schols, AM

    1. Pouw, EM et al "Muscle metabolic status in patients with severe COPD with and without long-term prednisolone." European Respiratory Journal 16.2 (2000): 247-252. Web. 24 June. 2021.

  3. Schwoebel, V

    1. Schwoebel, V et al "Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group." European Respiratory Journal 16.2 (2000): 364-371. Web. 24 June. 2021.

  4. Sharp, JM

    1. De las Heras, M et al "Evidence for a protein related immunologically to the jaagsiekte sheep retrovirus in some human lung tumours." European Respiratory Journal 16.2 (2000): 330-332. Web. 24 June. 2021.

  5. Smith, A

    1. Raeside, DA et al "Pulmonary artery pressure measurement during exercise testing in patients with suspected pulmonary hypertension." European Respiratory Journal 16.2 (2000): 282-287. Web. 24 June. 2021.

  6. Steenhuis, LH

    1. Steenhuis, LH et al "Diffusion capacity and haemodynamics in primary and chronic thromboembolic pulmonary hypertension." European Respiratory Journal 16.2 (2000): 276-281. Web. 24 June. 2021.

  7. Steurer, J

    1. Stey, C et al "The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review." European Respiratory Journal 16.2 (2000): 253-262. Web. 24 June. 2021.

  8. Stey, C

    1. Stey, C et al "The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review." European Respiratory Journal 16.2 (2000): 253-262. Web. 24 June. 2021.

  9. Swenson, ER

    1. Brogan, TV et al "Pulmonary NO synthase inhibition and inspired CO2: effects on V'/Q' and pulmonary blood flow distribution." European Respiratory Journal 16.2 (2000): 288-295. Web. 24 June. 2021.

T

  1. Thomsen, VO

    1. Thomsen, VO et al "Results from 8 yrs of susceptibility testing of clinical Mycobacterium tuberculosis isolates in Denmark." European Respiratory Journal 16.2 (2000): 203-208. Web. 24 June. 2021.

  2. Tramer, MR

    1. Stey, C et al "The effect of oral N-acetylcysteine in chronic bronchitis: a quantitative systematic review." European Respiratory Journal 16.2 (2000): 253-262. Web. 24 June. 2021.

  3. Tukiainen, H

    1. Purokivi, M et al "Reproducibility of measurements of exhaled NO, and cell count and cytokine concentrations in induced sputum." European Respiratory Journal 16.2 (2000): 242-246. Web. 24 June. 2021.

U

  1. Uhlig, S

    1. Martin, C, V Ullrich, and S Uhlig. "Effects of the thromboxane receptor agonist U46619 and endothelin-1 on large and small airways." European Respiratory Journal 16.2 (2000): 316-323. Web. 24 June. 2021.

  2. Ullrich, V

    1. Martin, C, V Ullrich, and S Uhlig. "Effects of the thromboxane receptor agonist U46619 and endothelin-1 on large and small airways." European Respiratory Journal 16.2 (2000): 316-323. Web. 24 June. 2021.

V

  1. van der Mark, TW

    1. Steenhuis, LH et al "Diffusion capacity and haemodynamics in primary and chronic thromboembolic pulmonary hypertension." European Respiratory Journal 16.2 (2000): 276-281. Web. 24 June. 2021.

  2. van der Vusse, GJ

    1. Pouw, EM et al "Muscle metabolic status in patients with severe COPD with and without long-term prednisolone." European Respiratory Journal 16.2 (2000): 247-252. Web. 24 June. 2021.

  3. Veen, J

    1. Borgdorff, MW et al "Defaulting from tuberculosis treatment in The Netherlands: rates, risk factors and trend in the period 1993-1997." European Respiratory Journal 16.2 (2000): 209-213. Web. 24 June. 2021.

  4. Vestbo, J

    1. Vestbo, J, and P Lange. "Is lung function really a good parameter in evaluating the long-term effects of inhaled corticosteroids in COPD?." European Respiratory Journal 16.2 (2000): 372-373. Web. 24 June. 2021.

  5. Villafranca, C

    1. Diaz, O et al "Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest." European Respiratory Journal 16.2 (2000): 269-275. Web. 24 June. 2021.

W

  1. Wagner, M

    1. De las Heras, M et al "Evidence for a protein related immunologically to the jaagsiekte sheep retrovirus in some human lung tumours." European Respiratory Journal 16.2 (2000): 330-332. Web. 24 June. 2021.

  2. Ware, SI

    1. Reddel, HK et al "Optimal asthma control, starting with high doses of inhaled budesonide." European Respiratory Journal 16.2 (2000): 226-235. Web. 24 June. 2021.

  3. Woolcock, AJ

    1. Reddel, HK et al "Optimal asthma control, starting with high doses of inhaled budesonide." European Respiratory Journal 16.2 (2000): 226-235. Web. 24 June. 2021.

  4. Wouters, EF

    1. Pouw, EM et al "Muscle metabolic status in patients with severe COPD with and without long-term prednisolone." European Respiratory Journal 16.2 (2000): 247-252. Web. 24 June. 2021.

X

  1. Xuan, W

    1. Reddel, HK et al "Optimal asthma control, starting with high doses of inhaled budesonide." European Respiratory Journal 16.2 (2000): 226-235. Web. 24 June. 2021.

Z

  1. Zellweger, JP

    1. Helbling, P et al "Surveillance of antituberculosis drug resistance in Switzerland 1995-1997: the central link." European Respiratory Journal 16.2 (2000): 200-202. Web. 24 June. 2021.

  2. Zin, WA

    1. Antonaglia, V et al "Bedside assessment of respiratory viscoelastic properties in ventilated patients." European Respiratory Journal 16.2 (2000): 302-308. Web. 24 June. 2021.
Back to top

Search Within This Issue

Jump to

Manage Table of content Alerts